Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

TIPRANAVIR vs TISAGENLECLEUCEL: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

TIPRANAVIR vs TISAGENLECLEUCEL: Safety Overview

Metric TIPRANAVIR TISAGENLECLEUCEL
Total FAERS Reports 403 4,229
Deaths Reported 14 1,232
Death Rate 3.5% 29.1%
Hospitalizations 261 1,256
Average Patient Age 48.2 yrs 39.1 yrs
% Female Patients 82.9% 38.4%
FDA Approval Date Jun 22, 2005 N/A
Manufacturer Boehringer Ingelheim Pharmaceuticals,... Novartis Pharmaceuticals Corporation
Route ORAL INTRAVENOUS
Marketing Status Prescription N/A